Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 22
08/09/2017 5:43:16 PM
08/08/2017 1:31:18 PM
08/08/2017 1:26:58 PM
08/08/2017 1:24:18 PM
08/01/2017 4:41:03 PM
08/01/2017 4:39:27 PM
07/27/2017 4:21:24 PM
07/27/2017 4:10:53 PM
07/27/2017 4:09:43 PM
07/27/2017 3:52:00 PM
07/26/2017 4:03:05 PM
07/26/2017 4:01:43 PM
07/26/2017 3:58:50 PM
07/26/2017 3:55:10 PM
07/25/2017 2:29:14 PM
07/25/2017 2:14:30 PM
07/25/2017 2:08:17 PM
07/25/2017 2:03:22 PM
07/24/2017 12:52:05 PM
07/24/2017 12:50:50 PM
07/24/2017 12:47:28 PM
07/24/2017 12:43:35 PM
07/24/2017 12:41:15 PM
07/21/2017 1:55:30 PM
07/21/2017 1:54:31 PM
07/21/2017 1:53:35 PM
07/21/2017 1:52:01 PM
07/21/2017 1:47:27 PM
06/21/2017 1:46:57 PM
06/21/2017 1:46:04 PM
06/21/2017 1:44:37 PM
06/21/2017 1:43:55 PM
06/21/2017 1:42:24 PM
06/20/2017 2:46:58 PM
06/20/2017 2:45:18 PM
06/20/2017 2:44:27 PM
06/20/2017 2:42:48 PM
06/20/2017 2:41:54 PM
06/19/2017 1:21:38 PM
06/19/2017 1:18:31 PM
06/19/2017 1:14:23 PM
06/19/2017 1:10:21 PM
06/19/2017 1:07:33 PM
06/15/2017 3:11:45 PM
06/15/2017 3:11:03 PM
06/15/2017 3:10:06 PM
06/15/2017 3:09:25 PM
06/15/2017 3:08:16 PM
06/14/2017 2:52:56 PM
06/14/2017 2:50:27 PM
Recent Articles
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
- Investigation of MoonLake Immunotherapeutics Raises Concerns
- Leadership Changes at Silver Mountain Resources: What to Expect
- Canton Fair Launches Enhanced Services to Boost Global Trade
